SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052582
Filing Date
2020-11-09
Accepted
2020-11-09 16:59:07
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-10q_20200930.htm   iXBRL 10-Q 2090230
2 EX-10.1 ljpc-ex101_91.htm EX-10.1 46215
3 EX-31.1 ljpc-ex311_90.htm EX-31.1 18324
4 EX-31.2 ljpc-ex312_89.htm EX-31.2 18396
5 EX-32.1 ljpc-ex321_88.htm EX-32.1 15106
6 GRAPHIC gpjplj52twtq000001.jpg GRAPHIC 3670
7 GRAPHIC guw1raetlset000001.jpg GRAPHIC 37504
  Complete submission text file 0001564590-20-052582.txt   6713452

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20200930.xsd EX-101.SCH 48677
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ljpc-20200930_cal.xml EX-101.CAL 59602
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ljpc-20200930_def.xml EX-101.DEF 173061
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20200930_lab.xml EX-101.LAB 390492
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20200930_pre.xml EX-101.PRE 296758
13 EXTRACTED XBRL INSTANCE DOCUMENT ljpc-10q_20200930_htm.xml XML 961568
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 201298564
SIC: 2836 Biological Products, (No Diagnostic Substances)